166 related articles for article (PubMed ID: 22246278)
1. Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome.
Yang Y; Zhang Q; Xu F; Wu L; He Q; Li X
J Cancer Res Clin Oncol; 2012 May; 138(5):729-37. PubMed ID: 22246278
[TBL] [Abstract][Full Text] [Related]
2. Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome.
Yang Y; Zhang Q; Xu F; Chang C; Li X
Eur J Haematol; 2012 Dec; 89(6):469-77. PubMed ID: 23005040
[TBL] [Abstract][Full Text] [Related]
3. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
[TBL] [Abstract][Full Text] [Related]
4. [Study of aberrant p73 promoter methylation in patients with myelodysplastic syndrome].
Zhao YS; Yang R; Gu SC; Guo J; Zhang X; Wu LY; Li X; Chang CK
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):847-51. PubMed ID: 23384909
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic changes in FOXO3 and CHEK2 genes and their correlation with clinicopathological findings in myelodysplastic syndromes.
Sharifi MJ; Zaker F; Nasiri N; Yaghmaie M
Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):214-219. PubMed ID: 32217071
[TBL] [Abstract][Full Text] [Related]
6. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment.
Daskalakis M; Nguyen TT; Nguyen C; Guldberg P; Köhler G; Wijermans P; Jones PA; Lübbert M
Blood; 2002 Oct; 100(8):2957-64. PubMed ID: 12351408
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of hypermethylation of DLC-1 gene in myelodysplastic syndrome patients and effects of decitabine on DLC-1 gene expression].
Fu HY; Zhou HR; Yan JG; Chen CJ; Shen JZ
Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(6):412-417. PubMed ID: 28219126
[No Abstract] [Full Text] [Related]
8. Hypermethylation of the p15INK4B gene in myelodysplastic syndromes.
Uchida T; Kinoshita T; Nagai H; Nakahara Y; Saito H; Hotta T; Murate T
Blood; 1997 Aug; 90(4):1403-9. PubMed ID: 9269757
[TBL] [Abstract][Full Text] [Related]
9. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.
Jiang Y; Dunbar A; Gondek LP; Mohan S; Rataul M; O'Keefe C; Sekeres M; Saunthararajah Y; Maciejewski JP
Blood; 2009 Feb; 113(6):1315-25. PubMed ID: 18832655
[TBL] [Abstract][Full Text] [Related]
10. [Detection of methylation levels of multi-genes by real-time PCR in patients with myelodysplastic syndrome].
Wang YC; DU X; Geng SX; Li YY; Weng JY; Lu ZS; Zhong LY; Deng CX; Lai PL; Huang X
Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):254-8. PubMed ID: 21569709
[TBL] [Abstract][Full Text] [Related]
11. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma.
Liu XQ; Chen HK; Zhang XS; Pan ZG; Li A; Feng QS; Long QX; Wang XZ; Zeng YX
Int J Cancer; 2003 Aug; 106(1):60-5. PubMed ID: 12794757
[TBL] [Abstract][Full Text] [Related]
12. [Methylation status of ZO-1 gene in patients with myelodysplastic syndrome].
Kang HY; Wang C; Dou LP; Qing Y; Han XP; Sun JF; Liu CH; Lu XC; Liu Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):70-3. PubMed ID: 18315903
[TBL] [Abstract][Full Text] [Related]
13. Absence of NPM1 promoter hypermethylation in human myelodysplastic syndrome.
Cheng YY; Chau D; Chan T; Gill H; Liang R; Kwong YL; Tse E
J Clin Pathol; 2010 Nov; 63(11):1008-11. PubMed ID: 20924036
[TBL] [Abstract][Full Text] [Related]
14. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
15. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
[TBL] [Abstract][Full Text] [Related]
16. [Methylation of FHIT gene promoter region in DNA from plasma of patients with myelodysplastic syndromes and demethylating effect of decitabine].
Deng YF; Zhang L; Zhang XQ; Hu MQ; Dai D; Zhang XZ; Xu YL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1144-8. PubMed ID: 23114136
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of BLU is associated with methylation of Sp1-binding site of BLU promoter in gastric cancer.
Xiao K; Yu Z; Shi DT; Lei Z; Chen H; Cao J; Tian W; Chen W; Zhang HT
Int J Oncol; 2015 Aug; 47(2):621-31. PubMed ID: 26043875
[TBL] [Abstract][Full Text] [Related]
18. Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms.
Schmelz K; Sattler N; Wagner M; Lübbert M; Dörken B; Tamm I
Leukemia; 2005 Jan; 19(1):103-11. PubMed ID: 15510208
[TBL] [Abstract][Full Text] [Related]
19. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes.
Sawanobori M; Yamaguchi S; Hasegawa M; Inoue M; Suzuki K; Kamiyama R; Hirokawa K; Kitagawa M
Leuk Res; 2003 Jul; 27(7):583-91. PubMed ID: 12681357
[TBL] [Abstract][Full Text] [Related]
20. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
